You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ZYPREXA ZYDIS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ZYPREXA ZYDIS

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000374 ↗	Treatment for First-Episode Schizophrenia	Completed	National Institute of Mental Health (NIMH)	Phase 4	1998-09-01	This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
NCT00000374 ↗	Treatment for First-Episode Schizophrenia	Completed	The Zucker Hillside Hospital	Phase 4	1998-09-01	This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
NCT00000374 ↗	Treatment for First-Episode Schizophrenia	Completed	Northwell Health	Phase 4	1998-09-01	This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
NCT00044655 ↗	Switching Medication to Treat Schizophrenia	Completed	National Institute of Mental Health (NIMH)	Phase 4	2001-07-01	This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ZYPREXA ZYDIS

Condition Name

Chart
Table

Condition Name for ZYPREXA ZYDIS
Intervention	Trials
Schizophrenia	49
Schizoaffective Disorder	15
Bipolar Disorder	12
Healthy	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ZYPREXA ZYDIS
Intervention	Trials
Schizophrenia	51
Psychotic Disorders	22
Disease	16
Bipolar Disorder	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ZYPREXA ZYDIS

Trials by Country

Map
Table

Trials by Country for ZYPREXA ZYDIS
Location	Trials
United States	238
Canada	20
Spain	7
Russian Federation	6
China	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ZYPREXA ZYDIS
Location	Trials
New York	27
California	18
Pennsylvania	13
Ohio	12
Massachusetts	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ZYPREXA ZYDIS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ZYPREXA ZYDIS
Clinical Trial Phase	Trials
Phase 4	40
Phase 3	29
Phase 2/Phase 3	4
[disabled in preview]	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ZYPREXA ZYDIS
Clinical Trial Phase	Trials
Completed	93
Terminated	16
Recruiting	6
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ZYPREXA ZYDIS

Sponsor Name

Chart
Table

Sponsor Name for ZYPREXA ZYDIS
Sponsor	Trials
Eli Lilly and Company	30
National Institute of Mental Health (NIMH)	17
New York State Psychiatric Institute	4
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ZYPREXA ZYDIS
Sponsor	Trials
Other	131
Industry	67
NIH	21
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.